Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Outcomes of Concurrent Chemoradiotherapy in Patients With Stage III Non-Small-Cell Lung Cancer and S
Link ID 34649
Title Outcomes of Concurrent Chemoradiotherapy in Patients With Stage III Non-Small-Cell Lung Cancer and S
Url http://www.medscape.com/viewarticle/736309?src=rss
Description Authors evaluated NSCLC outcomes in patients treated with cisplatin-based chemotherapy who were selected by using radiation planning parameters. Annals of Oncology
Category Articles > Hematology-Oncology
Keywords
Date Mar 22, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Mounting Evidence That Agent Orange Exposure Ups Prostate Cancer Risk
  A study of nearly 3000 veterans showed that men exposed to Agent Orange in Vietnam were 49% more likely to be diagnosed with prostate cancer than men who were not exposed to the defoliate. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Prompt Exam Urged for Pelvic Symptoms Late After Radiation
  Radiation-associated endometrial cancers carry a grave prognosis, possibly because of delayed presentation and diagnosis, according to findings published in the February issue of Obstetrics and Gynecology. Reuters Health Information
Category:   Articles > Hematology-Oncology


3. Major and Notable Cancer Advances in 2010
  Advances in clinical cancer research considered to be either major or notable are listed by the American Society of Clinical Oncology in its annual report. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. FDA Approves Eribulin for Late-Stage Breast Cancer
  The FDA has approved eribulin mesylate injection for the treatment of metastatic breast cancer in patients who have received at least 2 prior chemotherapy regimens for late-stage disease. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. FDA Approves Denosumab for Patients With Cancer FDA Approves Denosumab for Patients With Cancer
  The bone-modifying drug is now indicated to increase bone mass and reduce fracture risk in men and women undergoing hormone ablation therapy for cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS